Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
Join the waitlist on the Better You Rx website
The ICD-10 code microcytic anemia coders reach for is not a single code
BSO is an inhibitor of GSH synthase that has been used to deplete GSH in vitro , including in macrophages ( We analyzed the gene expression profile and identified patterns of LPS-induced genes that were inhibited by endogenous GSH or that, on the contrary, required GSH for their induction
Takeaway: Maintain your heart health with vitamin D The cellular activity of heart tissue is intimately linked to vitamin D, which is also essential for preserving the calcium balance that directly controls nerve impulses and heart contractions
At Creative Touch Training, were dedicated to helping you succeed whether youre investing in your skills through our courses or purchasing professional beauty products
